Loading

Veterans

  • by Paul Armentano, NORML Deputy Director October 30, 2017

    medical_mj_shelfMembers of the US House Committee on Veteran’s Affairs are demanding the Department of Veterans Affairs facilitate protocols to assess the efficacy of medical cannabis in veterans suffering from chronic pain and post-traumatic stress.

    Minnesota Democrat Tim Walz, along with nine other Democrat members of the Committee, authored an October 26, 2017 letter to VA Secretary David Shulkin stating: “[The] VA is uniquely situated to pursue research on the impact of medical marijuana on veterans suffering from chronic pain and PTSD given its access to world class researchers, the population it serves, and its history of overseeing and producing research resulting in cutting-edge medical treatments. … VA’s pursuit of research into the impact of medical marijuana on the treatment of veterans diagnosed with PTSD who are also experiencing chronic pain is integral to the advancement of health care for veterans and the nation. We ask VA to respond … with a commitment to the development of VHA-led research into this issue.”

    In September, representatives from The American Legion addressed a separate letter to VA Secretary Shulkin encouraging the VA assist in an ongoing, FDA-approved clinical trial assessing the safety and efficacy of various strains of cannabis in veterans with PTSD. To date, the VA has refused to assist in patient recruitment for the trial. The VA has yet to publicly respond to the Legion’s letter.

    Survey data finds that military veterans report using cannabis therapeutically at rates far higher than the do those in the general population, and that many are already using it as an alternative to conventional medications in the treatment of pain and post-traumatic stress.

  • by Carly Wolf, NORML Political Associate October 6, 2017

    The American Legion has been calling on the federal government for over a year – specifically the Veterans Affairs Department – to support research into the therapeutic benefits of cannabis in treating veterans with PTSD.

    Many veterans have told both the Legion and NORML that they have been able to eliminate or reduce their dependency on other drugs, specifically opioids, by using cannabis.

    The Legion recently ramped up their efforts to convince VA Secretary Shulkin to expand research into the therapeutic and medicinal effects of cannabis by sending him a letter demanding for his direct involvement in making sure the medical marijuana study meets its goals.

    That letter was sent on September 19th. 17 days ago.

    Has Secretary Shulkin or the Dept. of Veterans Affairs responded? No. Have either even acknowledged receipt of the letter? To public knowledge, no.

    Why hasn’t Sec. Shulkin or the VA responded? Is he going to listen to the nation’s largest Veterans advocacy group? One that is pleading for help that our veterans so desperately need and deserve? Great question. The American Legion seems to be wondering the same thing.

    Screen Shot 2017-10-06 at 12.24.17 PM

    The Legion has been expressing their frustration on Twitter for Sec. Shulkin’s failure to act on this pressing issue.

    Screen Shot 2017-10-06 at 12.36.06 PM

     

    Screen Shot 2017-10-06 at 12.46.37 PM

    Secretary Shulkin is doing himself, our veterans, and to a larger extent, our nation, a huge disservice by not acknowledging the Legion’s cry for help and support.

    Join us in calling upon Secretary Shulkin to listen to the pleas of Veterans.

    Share one or more of the following tweets (and this blog on all of your accounts):

    Why hasn’t @SecShulkin responded to @AmericanLegion call for help? https://twitter.com/AmericanLegion/status/911576050043408384

    .@SecShulkin failure to act on this issue is hurting our veterans. @AmericanLegion
    https://twitter.com/AmericanLegion/status/913010589668188160

    RT to help the @AmericanLegion call upon @SecShulkin to take action on behalf of veterans

  • by Justin Strekal, NORML Political Director September 20, 2017

    legion_displayFor more than a year, The American Legion has been calling on the federal government – and specifically the Veterans Affairs Department – to support research into the therapeutic benefits of cannabis in treating veterans with PTSD.

    Many veterans, especially Iraq and Afghanistan combat veterans, have told both the Legion and NORML that they have been able to eliminate or reduce their dependency on other drugs, specifical opioids.

    Now, the Legion is ramping up their efforts to convince VA Secretary Shulkin to expand research into the therapeutic and medicinal effects of cannabis.

    In a letter sent yesterday and released publicly today, they state:

    Dear Mr. Secretary:

    For more than a year, the American Legion has called on the federal government to support and enable scientific research to clinically confirm the medicinal value of cannabis. The National Academy of Medicine recently reviewed 10,000 scientific abstracts on the therapeutic value of cannabis and reached nearly 100 conclusions in a report issued earlier this year. As a two million member strong veteran service organization, our primary interest and advocacy is grounded in the wellbeing and improved health of our veterans, and specifically our service disabled veterans.

    The American Legion supports VA’s statutory medical research million and has donated millions of dollars toward expanding VA’s scientific research. VA innovation is widely championed for its breakthrough discoveries in medicine and has been recognized over the years with three Nobel Prizes for scientific work that has benefitted the world over.

    Your immediate attention in this important matter is greatly appreciated. We ask for your direct involvement to ensure this critical research is fully implemented.

    Sincerely,
    Denise H. Rohan
    National Commander

    This comes just one month after the Legion adopted a resolution calling on federal officials to expand veterans’ access to medical marijuana.

    NORML has documented the longitudinal data on how cannabis access is associated with reduced rates of opioid use and abuse, opioid-related hospitalizations, opioid-related traffic fatalities, and opioid-related overdose deaths

    You can read the full letter to VA urging cannabis research access here.

    Click here to send a message to your federal officials in support of HR 1820, the bipartisan Veterans Equal Access Act introduced by Congressional Cannabis Caucus Co-Chair Earl Blumenauer

    Earlier this year, a budget amendment that reflected the Veterans Equal Access Act’s language was introduced by Senator Daines (R-MT) and passed in the Senate Appropriations Committee and introduced by Rep. Blumenauer and blocked in the House Rules Committee. The amendments fate will likely be decided in a joint conference committee later this year.

  • by Justin Strekal, NORML Political Director July 26, 2017

    3410000930_95fc2866fa_zTwo weeks ago, the Senate Appropriations Committee voted 24-7 to include the Veterans Equal Access amendment, introduced by Senator Daines (R-MT) as part of the 2018 Military Construction, Veterans Affairs and Related Agencies Appropriations bill, which would expand much needed medical marijuana access to our nation’s veterans.

    Yet House Rules Committee Chairman Pete Sessions (R-TX) decided that he did not want the full House to be able to vote on this critical amendment.

    Rep. Earl Blumenauer (D-OR), the amendments lead sponsor, testified before the committee that it was “a critical area of literally life and death.”

    Veterans are increasingly turning to medical cannabis as an effective alternative to opioids and other conventional medications to treat conditions like chronic pain and post-traumatic stress. A retrospective review of patients’ symptoms published in 2014 in the Journal of Psychoactive Drugs reported a greater than 75 percent reduction on a scale of post-traumatic symptom scores following cannabis therapy. This is why, in recent months, two of the largest veterans’ rights groups — AMVETS and the American Legion —  have resolved in favor of patients’ access to cannabis therapy.

    Last year, majorities in both the US House and Senate voted to include similar language as part of the Fiscal Year 2017 MilCon-VA bill. However, Republicans sitting on the House Appropriations Committee elected to remove the language from the bill during a concurrence vote.

    It is time that lawmakers stop playing politics with veterans’ health and pass and enact this amendment. There is still the possibility of the Senate’s amendment making it through the conference committee so make your voice heard.

    You can send a message to your elected officials in support of veterans having access to medical marijuana by clicking HERE.

  • by Justin Strekal, NORML Political Director July 13, 2017

    Marijuana medicineToday, the Senate Appropriations Committee voted 24-7 to include the Veterans Equal Access amendment as part of the 2018 Military Construction, Veterans Affairs and Related Agencies Appropriations bill, which would expand much needed medical marijuana access to our nation’s veterans.

    Presently, V.A. doctors in states where cannabis therapy is permitted are forbidden from providing the paperwork necessary to complete a medical cannabis recommendation, thus forcing military veterans to seek the advice of a private, out-of-network physician.

    Veterans are increasingly turning to medical cannabis as an effective alternative to opioids and other conventional medications to treat conditions like chronic pain and post-traumatic stress. A retrospective review of patients’ symptoms published in 2014 in the Journal of Psychoactive Drugs reported a greater than 75 percent reduction on a scale of post-traumatic symptom scores following cannabis therapy. This is why, in recent months, two of the largest veterans’ rights groups — AMVETS and the American Legion —  have resolved in favor of patients’ access to cannabis therapy.

    The amendment was introduced by Senator Daines, R-Montana for the second year in a row. Last year, majorities in both the US House and Senate voted to include similar language as part of the Fiscal Year 2017 Military Construction, Veterans Affairs and Related Agencies Appropriations bill. However, Republicans sitting on the House Appropriations Committee elected to remove the language from the bill during a concurrence vote.

    The 24-7 roll call was an increase over last years 20-10 appropriations passage. The changes came from Senators Susan Collins (R-ME), Senator John Hoeven (R-ND) and Jerry Moran (R-KS) all voting “aye” after having voted against the effort last year and both new members of the committee, Senators John Kennedy (R-LA) and Joe Manchin (D-WV) voting in favor.

    Identical language is expected to receive a vote in the House later this year. Keep an eye on NORML’s Act page for that and other changes.

Page 1 of 212